Clinical Trials Browser

Phase 2 × Central Nervous System Neoplasms × Rosiglitazone × Clear all

NCT00616642 2020-08-14

Rosiglitazone in Treating Patients With Pituitary Tumors

Phase 2 Terminated

1 enrolled 4 charts

Pituitary Neoplasms, Central Nervous System Neoplasms